Meningioma Clinical Trials

39 recruiting

Meningioma Trials at a Glance

56 actively recruiting trials for meningioma are listed on ClinicalTrialsFinder across 6 cities in 20 countries. The largest study group is Phase 2 with 18 trials, with the heaviest enrollment activity in Miami, Columbus, and New York. Lead sponsors running meningioma studies include Centre Francois Baclesse, Dartmouth-Hitchcock Medical Center, and Maastricht Radiation Oncology.

Browse meningioma trials by phase

Treatments under study

About Meningioma Clinical Trials

Looking for clinical trials for Meningioma? There are currently 39 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Meningioma trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Meningioma clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 56 trials

Recruiting
Phase 1Phase 2

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

ParagangliomaPheochromocytomaMeningioma+4 more
Perspective Therapeutics300 enrolled19 locationsNCT05636618
Recruiting
Phase 2

Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment

Intracranial Meningioma
RTOG Foundation, Inc.153 enrolled11 locationsNCT06955169
Recruiting
Not Applicable

NK Cell Therapy for Malignant Solid Brain Tumors

Brain MetastasisGlioblastoma Multiforme (GBM)Glioblastoma (GBM)+2 more
Peking University Third Hospital27 enrolled4 locationsNCT07552233
Recruiting
Phase 2

Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

Grade 2 MeningiomaRecurrent MeningiomaGrade 1 Meningioma+2 more
Mayo Clinic42 enrolled1 locationNCT04082520
Recruiting
Phase 1Phase 2

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

MeningiomaRecurrent Diffuse Intrinsic Pontine GliomaHigh Grade Glioma+10 more
Nationwide Children's Hospital65 enrolled4 locationsNCT05278208
Recruiting
Phase 2

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Intracranial MeningiomaRecurrent MeningiomaNF2 Gene Mutation
Alliance for Clinical Trials in Oncology124 enrolled781 locationsNCT02523014
Recruiting
Phase 2

Regorafenib for Recurrent Meningioma (MIRAGE Trial)

Meningioma, Malignant
Istituto Oncologico Veneto IRCCS104 enrolled17 locationsNCT06275919
Recruiting
Not Applicable

Comparison of Skin Closure Techniques in Oncological Neurosurgical Procedures: Intradermal Running Suture Versus Transdermal Interrupted Sutures

GlioblastomaMeningiomaGlioma+2 more
Medical University of Warsaw382 enrolled1 locationNCT07413796
Recruiting
Phase 2

Abemaciclib in Newly Diagnosed Meningioma Patients

Meningioma
Nader Sanai72 enrolled1 locationNCT05940493
Recruiting
Not Applicable

Plasma Extracellular Vesicles in Meningioma Patients

Meningioma
University Hospital Heidelberg60 enrolled1 locationNCT06104930
Recruiting

Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome

CholangiocarcinomaHepatocellular CarcinomaRenal Cell Carcinoma+5 more
Mohamed Abdel-Rahman500 enrolled1 locationNCT04792463
Recruiting
Phase 2

Cabozantinib for Patients With Recurrent or Progressive Meningioma

Meningioma
Baptist Health South Florida24 enrolled3 locationsNCT05425004
Recruiting
Phase 2

NEO100 and High-Grade Meningioma

Residual, Progressive or Recurrent Grade II or III Meningioma
Neonc Technologies, Inc.30 enrolled3 locationsNCT05023018
Recruiting
Phase 4

Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE

Meningioma
Weill Medical College of Cornell University20 enrolled1 locationNCT06377371
Recruiting
Not Applicable

Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study

SchwannomaIntracranial NeoplasmGrade I Meningioma+4 more
Emory University70 enrolled1 locationNCT04278118
Recruiting

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

Brain TumorBrain Tumor - MetastaticBrain Tumor, Recurrent+3 more
GT Medical Technologies, Inc.600 enrolled54 locationsNCT04427384
Recruiting
Not Applicable

3D MRE-Based Evaluation of Meningioma Mechanical Properties and Histological Features

Meningioma
Shengjing Hospital300 enrolled1 locationNCT06955208
Recruiting

Epigenetic Profiling and Liquid Biopsy: Perspectives for Personalized Medicine in Meningioma Patients - MIND

MeningiomaMeningioma of Brain
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta210 enrolled1 locationNCT07282470
Recruiting

Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial Tumors

GlioblastomaMeningiomaGlioma+4 more
Medical University of Warsaw200 enrolled1 locationNCT07411690
Recruiting
Not Applicable

Evaluation of the CONVIVO System

Brain MetastasesGlioblastomaMeningioma+3 more
Dartmouth-Hitchcock Medical Center30 enrolled1 locationNCT05139277